These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4432372)

  • 1. Studies on the origin of pandemic influenza. IV. Selection and transmission of "new" influenza viruses in vivo.
    Webster RG; Campbell CH
    Virology; 1974 Dec; 62(2):404-13. PubMed ID: 4432372
    [No Abstract]   [Full Text] [Related]  

  • 2. The in vivo production of "new" influenza A viruses. II. In vivo isolation of "new" viruses.
    Webster RG; Campbell CH
    Virology; 1972 May; 48(2):528-36. PubMed ID: 4112504
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigens (and recombinants) and immune response to avian influenza.
    Easterday BC
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):503-4. PubMed ID: 1092217
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of influenza virus neuraminidase in immunity.
    Rott R; Becht H; Orlich M
    J Gen Virol; 1974 Jan; 22(1):35-41. PubMed ID: 4855928
    [No Abstract]   [Full Text] [Related]  

  • 5. Temperature-Sensitive mutants of influenza virus. VII. Transfer of the TS-1[E] lesions to a wild-type influenza A virus with the HON1 surface antigens.
    Murphy BR; Spring SB; Richman DD; Tierney EL; Kasel J; Chanock RM
    Virology; 1975 Aug; 66(2):533-41. PubMed ID: 1171556
    [No Abstract]   [Full Text] [Related]  

  • 6. On the origin of pandemic influenza viruses.
    Webster RG
    Curr Top Microbiol Immunol; 1972; 59():75-105. PubMed ID: 4570690
    [No Abstract]   [Full Text] [Related]  

  • 7. The "in vivo" production of "new" influenza A viruses. I. Genetic recombination between avian and mammalian influenza viruses.
    Webster RG; Campbell CH; Granoff A
    Virology; 1971 May; 44(2):317-28. PubMed ID: 5565817
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuation of pathogenicity of fowl plague virus by recombination with other influenza A viruses nonpathogenic for fowl: nonexculsive dependence of pathogenicity on hemagglutinin and neuraminidase of the virus.
    Rott R; Orlich M; Scholtissek C
    J Virol; 1976 Jul; 19(1):54-60. PubMed ID: 985888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):81-91. PubMed ID: 1029759
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Virology; 1976 Feb; 69(2):511-22. PubMed ID: 1258359
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies with avian influenza A viruses: cross protection experiments in chickens.
    Allan WH; Madeley CR; Kendal AP
    J Gen Virol; 1971 Aug; 12(2):79-84. PubMed ID: 5123326
    [No Abstract]   [Full Text] [Related]  

  • 12. From the National Institutes of Health. Summary of a meeting on the origin of pandemic influenza viruses.
    Laver WG; Webster RG; Chu CM
    J Infect Dis; 1984 Jan; 149(1):108-15. PubMed ID: 6198405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective action of liposome-incorporated surface antigens of the influenza virus by different methods of immunization].
    Burkhanov SA; Mazhul' LA; Torchilin VP; Ageeva ON; Saatov TS
    Vopr Virusol; 1988; 33(2):151-3. PubMed ID: 3414063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on anti-neuraminidase antibody response in serum after inoculation of influenza hemagglutinin vaccines].
    Hiromatsu Y; Sato Y; Inoguchi T; Umeno H; Kurosawa Y; Ishii K; Kobayashi K; Kaji M; Shingu T; Hayashida K
    Kansenshogaku Zasshi; 1984 May; 58(5):367-75. PubMed ID: 6434660
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza: its antigenic variation and ecology.
    Dowdle WR; Schild GC
    Bull Pan Am Health Organ; 1976; 10(3):193-5. PubMed ID: 187273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "in vivo" production of "new" influenza viruses. 3. Isolation of recombinant influenza viruses under simulated conditions of natural transmission.
    Webster RG; Campbell CH; Granoff A
    Virology; 1973 Jan; 51(1):149-62. PubMed ID: 4684582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antigenic and immunogenic activity of influenza virus virion components].
    Milovidova NI; Porubel' LA; Ginzburg VP; Gendon IuZ
    Vopr Virusol; 1974; (6):683-8. PubMed ID: 4446567
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of influenza B virus recombinants and their testing in humans for attenuation and immunogenicity.
    Beare AS; Sherwood JE; Callow KA; Craig JW
    Infect Immun; 1977 Feb; 15(2):347-53. PubMed ID: 844900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemagglutinin relationships of Hong Kong(H3) and Asian(H2) influenza strains delineated by antigen-specific recombinants.
    Dowdle WR; Marine WM; Coleman M; Knez V
    J Gen Virol; 1972 Aug; 16(2):127-34. PubMed ID: 5072364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.